Clinical Trials Related to BioNTech SE

Related studies linked through entity extraction aliases.

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Status: RECRUITING
Phase: PHASE2

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

Status: WITHDRAWN
Phase: PHASE2

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

Status: RECRUITING
Phase: PHASE2

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Status: RECRUITING
Phase: PHASE1/PHASE2

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

Status: COMPLETED
Phase: PHASE1/PHASE2

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Status: RECRUITING
Phase: PHASE3

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Status: RECRUITING
Phase: PHASE2/PHASE3

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

Status: RECRUITING
Phase: PHASE2

A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis

Status: COMPLETED
Phase: PHASE1

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy

Status: TERMINATED
Phase: PHASE1/PHASE2

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Status: RECRUITING
Phase: PHASE3

A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

Status: COMPLETED
Phase: PHASE3